Abstract
The immune response is regulated not only by the proliferation, differentiation, and activation of cells, but also by programmed cell death, called apoptosis. Fas ligand expressed in activated T cells binds to its receptor, Fas, and induces apoptosis in target cells. Two mouse mutations that cause autoimmune disease, lpr (lymphoproliferation) and gld (generalized lymphoproliferative disease), are mutations in Fas and FasL genes, respectively. Human patients showing phenotypes (Canale-Smith syndrome or autoimmune lymphoproliferative syndrome) similar to those in lpr mice also carry mutations in Fas. This is a good example of a case in which the identification of a mouse mutation has led to the understanding of a human disease.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received December 24, 1997 / Accepted January 5, 1998
Rights and permissions
About this article
Cite this article
Nagata, S. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: A lesson from the mouse model. J Hum Genet 43, 2–8 (1998). https://doi.org/10.1007/s100380050029
Published:
Issue Date:
DOI: https://doi.org/10.1007/s100380050029
This article is cited by
-
Lymphadenopathy, splenomegaly, intermittent neutropenia, and acute kidney injury: Answers
Pediatric Nephrology (2020)
-
Cellular and genetic mechanisms of self tolerance and autoimmunity
Nature (2005)
-
Signalling pathways of the TNF superfamily: a double-edged sword
Nature Reviews Immunology (2003)
-
T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cell lines but not in Burkitt's lymphoma
Leukemia (2002)
-
The protective effect of phorbol esters on Fas-mediated apoptosis in T cells. Transcriptional and postranscriptional regulation
Oncogene (2002)